Related Experiment Video
Updated: Mar 15, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Anti-arrhythmic strategies for atrial fibrillation: The role of computational modeling in discovery, development, and
Eleonora Grandi1, Mary M Maleckar2
1Department of Pharmacology, University of California Davis, Davis, USA.
Insights
Computational modeling offers a quantitative framework to understand atrial fibrillation (AF) mechanisms and test therapies. This approach aids in developing new treatments for AF, a common heart arrhythmia linked to stroke and heart failure.
Area of Science:
- Computational Biology
- Cardiovascular Research
- Medical Imaging and Modeling
Background:
- Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, increasing stroke and heart failure risk.
- Current AF treatments focus on stroke prevention (anticoagulation) and rate/rhythm control, but rate control is often symptomatically insufficient.
- Rhythm control strategies include antiarrhythmic drugs, electrical cardioversion, and ablation.
Purpose of the Study:
- To demonstrate how computational modeling can integrate multiscale data for a quantitative understanding of AF.
- To explore the use of computational models in identifying and testing pharmacological and electrical interventions for AF.
- To highlight the role of computational modeling in supporting clinical decisions for AF management.
Main Methods:
- Review of existing computational modeling approaches applied to atrial fibrillation research.
- Integration of multiscale data within quantitative frameworks.
- Analysis of how modeling aids in evaluating therapeutic strategies.
Main Results:
- Computational modeling provides insights into the complex, multiscale mechanisms underlying AF.
- Modeling facilitates the identification and preclinical testing of novel pharmacological and electrical therapies.
- The quantitative framework supports informed clinical decision-making for AF patients.
Conclusions:
- Computational modeling is a valuable tool for advancing AF research and therapy development.
- The field has evolved significantly, contributing to the preclinical development pipeline.
- Future directions include addressing challenges in multiscale data integration and model validation for clinical application.
Abstract:
Atrial fibrillation (AF), the most common cardiac arrhythmia, is associated with increased risk of cerebrovascular stroke, and with several other pathologies, including heart failure. Current therapies for AF are targeted at reducing risk of stroke (anticoagulation) and tachycardia-induced cardiomyopathy (rate or rhythm control). Rate control, typically achieved by atrioventricular nodal blocking drugs, is often insufficient to alleviate symptoms. Rhythm control approaches include antiarrhythmic drugs, electrical cardioversion, and ablation strategies. Here, we offer several examples of how computational modeling can provide a quantitative framework for integrating multiscale data to: (a) gain insight into multiscale mechanisms of AF; (b) identify and test pharmacological and electrical therapy and interventions; and (c) support clinical decisions. We review how modeling approaches have evolved and contributed to the research pipeline and preclinical development and discuss future directions and challenges in the field.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

